Search alternatives:
mg decrease » _ decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 241 - 260 results of 145,656 for search '(( 100 mg decrease ) OR ( 10 ((ng decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.13s Refine Results
  1. 241
    A proposed working model of how the GmNN1/FT2a-GmNYFA-C-GmENOD40 module regulates nodulation in soybean.

    A proposed working model of how the GmNN1/FT2a-GmNYFA-C-GmENOD40 module regulates nodulation in soybean. by Xinxin Li (281237)

    Published 2022
    Save to List
    Saved in:
  2. 242
    Relationships between ∑PAHs and altitude: Qunatong River watershed (a), and Yubeng River watershed (b).

    Relationships between ∑PAHs and altitude: Qunatong River watershed (a), and Yubeng River watershed (b). by Xinyu Wen (3693)

    Published 2025
    Save to List
    Saved in:
  3. 243
    ngLVA degradation kinetics.

    ngLVA degradation kinetics. by Nicole A. Grieshaber (11175417)

    Published 2022
    Save to List
    Saved in:
  4. 244
    Erectile function parameters showed that si-NgBR and ICAM-1 antibody treatments decreased blood glucose and ameliorated ED.

    Erectile function parameters showed that si-NgBR and ICAM-1 antibody treatments decreased blood glucose and ameliorated ED. by Yun Zhang (131894)

    Published 2019
    Save to List
    Saved in:
  5. 245
    Fig 3 -

    Fig 3 - by Jilei Hu (10156880)

    Published 2024
    Save to List
    Saved in:
  6. 246
    Fig 10 -

    Fig 10 - by Jie He (132999)

    Published 2024
    Save to List
    Saved in:
  7. 247
    Immunohistochemical analysis of PDGF-BB expression in various experimental groups; showing negative expression in control group, significant increased along the fibrous septa and along the sinusoidal areas (upper insert) in TAA administrated group, significant dose related decreased expression in RBO which showing scattered expression in the sinusoidal areas, and mild expression along the incomplete septa as well as in sinusoidal areas in silymarin treated group.

    Immunohistochemical analysis of PDGF-BB expression in various experimental groups; showing negative expression in control group, significant increased along the fibrous septa and a... by Rehab F. Abdel-Rahman (11886404)

    Published 2021
    Save to List
    Saved in:
  8. 248
    TMEM182 decreases OSCC cell motility.

    TMEM182 decreases OSCC cell motility. by En-Wei Hsing (154990)

    Published 2019
    Save to List
    Saved in:
  9. 249
    Maximum concentrations (ng/L) of 88 pharmaceuticals detected at least once (in order of decreasing number of detections across all regions and samples) in water samples from wadeable streams in each region as part of the USGS Regional Stream Quality Assessment (RSQA).

    Maximum concentrations (ng/L) of 88 pharmaceuticals detected at least once (in order of decreasing number of detections across all regions and samples) in water samples from wadeab... by Paul M. Bradley (523469)

    Published 2020
    Save to List
    Saved in:
  10. 250
    TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas’ heart disease

    TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas’ heart disease by Roberto Rodrigues Ferreira (7109207)

    Published 2019
    Save to List
    Saved in:
  11. 251
    Evaluation of glucose consumption and lactate production in culture medium of HL-1 cells exposed to LG, NG, HG and IHG during 12 and 72h.

    Evaluation of glucose consumption and lactate production in culture medium of HL-1 cells exposed to LG, NG, HG and IHG during 12 and 72h. by Patrick Mordel (17020879)

    Published 2023
    Save to List
    Saved in:
  12. 252
    Source data for Fig 1.

    Source data for Fig 1. by Rahsan Erdem (11726357)

    Published 2021
    Save to List
    Saved in:
  13. 253
    Source data for Fig 2.

    Source data for Fig 2. by Rahsan Erdem (11726357)

    Published 2021
    Save to List
    Saved in:
  14. 254
    Source data for Fig 3.

    Source data for Fig 3. by Rahsan Erdem (11726357)

    Published 2021
    Save to List
    Saved in:
  15. 255
    Demographics and baseline characteristics of the safety population.

    Demographics and baseline characteristics of the safety population. by Rahsan Erdem (11726357)

    Published 2021
    Save to List
    Saved in:
  16. 256
    Grading of stool consistency and diarrhea severity.

    Grading of stool consistency and diarrhea severity. by Rahsan Erdem (11726357)

    Published 2021
    Save to List
    Saved in:
  17. 257
    Secondary efficacy endpoints for the modified intent-to-treat population.

    Secondary efficacy endpoints for the modified intent-to-treat population. by Rahsan Erdem (11726357)

    Published 2021
    Save to List
    Saved in:
  18. 258
    Source data for S1 and S2 Figs.

    Source data for S1 and S2 Figs. by Rahsan Erdem (11726357)

    Published 2021
    Save to List
    Saved in:
  19. 259
    Consolidated Standards for Reporting of Trials flow diagram.

    Consolidated Standards for Reporting of Trials flow diagram. by Rahsan Erdem (11726357)

    Published 2021
    Save to List
    Saved in:
  20. 260
    Diarrheal disease severity by treatment group for the modified intent-to-treat population.

    Diarrheal disease severity by treatment group for the modified intent-to-treat population. by Rahsan Erdem (11726357)

    Published 2021
    Save to List
    Saved in:

Search Tools: